CLRB 10-Q: SEC filing
Cellectar Biosciences
Filed with the SEC on · accession 0001104659-26-124765
CLRB filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. Cellectar Biosciences filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, warrant fair value measurements, and preferred stock activity.
Summary of the filing
Cellectar Biosciences filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, warrant fair value measurements, and preferred stock activity. No single material corporate event is disclosed in the filing.
Key details
✦ Ask GOAX AI about this filing — what it means for CLRB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLRB?
Click hereFrequently asked questions
What did CLRB file with the SEC on Nov 10, 2026?
CLRB filed a 10-Q (SEC filing). Cellectar Biosciences filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, warrant fair value measurements, and preferred stock activity. No single material corporate event is disclosed in the filing.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other CLRB SEC filings
Get alerts when CLRB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days